190 related articles for article (PubMed ID: 29871875)
1. Trade-offs with stability modulate innate and mutationally acquired drug resistance in bacterial dihydrofolate reductase enzymes.
Matange N; Bodkhe S; Patel M; Shah P
Biochem J; 2018 Jun; 475(12):2107-2125. PubMed ID: 29871875
[TBL] [Abstract][Full Text] [Related]
2. Highly Contingent Phenotypes of Lon Protease Deficiency in Escherichia coli upon Antibiotic Challenge.
Matange N
J Bacteriol; 2020 Jan; 202(3):. PubMed ID: 31740490
[TBL] [Abstract][Full Text] [Related]
3. Biophysical principles predict fitness landscapes of drug resistance.
Rodrigues JV; Bershtein S; Li A; Lozovsky ER; Hartl DL; Shakhnovich EI
Proc Natl Acad Sci U S A; 2016 Mar; 113(11):E1470-8. PubMed ID: 26929328
[TBL] [Abstract][Full Text] [Related]
4. A single amino acid substitution in Staphylococcus aureus dihydrofolate reductase determines trimethoprim resistance.
Dale GE; Broger C; D'Arcy A; Hartman PG; DeHoogt R; Jolidon S; Kompis I; Labhardt AM; Langen H; Locher H; Page MG; Stüber D; Then RL; Wipf B; Oefner C
J Mol Biol; 1997 Feb; 266(1):23-30. PubMed ID: 9054967
[TBL] [Abstract][Full Text] [Related]
5. Analysis of mutational resistance to trimethoprim in Staphylococcus aureus by genetic and structural modelling techniques.
Vickers AA; Potter NJ; Fishwick CW; Chopra I; O'Neill AJ
J Antimicrob Chemother; 2009 Jun; 63(6):1112-7. PubMed ID: 19383727
[TBL] [Abstract][Full Text] [Related]
6. Structural comparison of chromosomal and exogenous dihydrofolate reductase from Staphylococcus aureus in complex with the potent inhibitor trimethoprim.
Heaslet H; Harris M; Fahnoe K; Sarver R; Putz H; Chang J; Subramanyam C; Barreiro G; Miller JR
Proteins; 2009 Aug; 76(3):706-17. PubMed ID: 19280600
[TBL] [Abstract][Full Text] [Related]
7. A trimethoprim derivative impedes antibiotic resistance evolution.
Manna MS; Tamer YT; Gaszek I; Poulides N; Ahmed A; Wang X; Toprak FCR; Woodard DR; Koh AY; Williams NS; Borek D; Atilgan AR; Hulleman JD; Atilgan C; Tambar U; Toprak E
Nat Commun; 2021 May; 12(1):2949. PubMed ID: 34011959
[TBL] [Abstract][Full Text] [Related]
8. Crystal structures of wild-type and mutant methicillin-resistant Staphylococcus aureus dihydrofolate reductase reveal an alternate conformation of NADPH that may be linked to trimethoprim resistance.
Frey KM; Liu J; Lombardo MN; Bolstad DB; Wright DL; Anderson AC
J Mol Biol; 2009 Apr; 387(5):1298-308. PubMed ID: 19249312
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the gene for chromosomal trimethoprim-sensitive dihydrofolate reductase of Staphylococcus aureus ATCC 25923.
Dale GE; Then RL; Stüber D
Antimicrob Agents Chemother; 1993 Jul; 37(7):1400-5. PubMed ID: 8363365
[TBL] [Abstract][Full Text] [Related]
10. Structure-guided functional studies of plasmid-encoded dihydrofolate reductases reveal a common mechanism of trimethoprim resistance in Gram-negative pathogens.
Krucinska J; Lombardo MN; Erlandsen H; Estrada A; Si D; Viswanathan K; Wright DL
Commun Biol; 2022 May; 5(1):459. PubMed ID: 35562546
[TBL] [Abstract][Full Text] [Related]
11. Increased substrate affinity in the Escherichia coli L28R dihydrofolate reductase mutant causes trimethoprim resistance.
Abdizadeh H; Tamer YT; Acar O; Toprak E; Atilgan AR; Atilgan C
Phys Chem Chem Phys; 2017 May; 19(18):11416-11428. PubMed ID: 28422217
[TBL] [Abstract][Full Text] [Related]
12. Improving protein solubility through rationally designed amino acid replacements: solubilization of the trimethoprim-resistant type S1 dihydrofolate reductase.
Dale GE; Broger C; Langen H; D'Arcy A; Stüber D
Protein Eng; 1994 Jul; 7(7):933-9. PubMed ID: 7971955
[TBL] [Abstract][Full Text] [Related]
13. E84G mutation in dihydrofolate reductase from drug resistant strains of Mycobacterium tuberculosis (Mumbai, India) leads to increased interaction with Trimethoprim.
Raju A; Kulkarni S; Ray MK; Rajan MG; Degani MS
Int J Mycobacteriol; 2015 Jun; 4(2):97-103. PubMed ID: 26972877
[TBL] [Abstract][Full Text] [Related]
14. Crowders Steal Dihydrofolate Reductase Ligands through Quinary Interactions.
Duff MR; Desai N; Craig MA; Agarwal PK; Howell EE
Biochemistry; 2019 Mar; 58(9):1198-1213. PubMed ID: 30724552
[TBL] [Abstract][Full Text] [Related]
15. Cloning and characterization of a novel trimethoprim-resistant dihydrofolate reductase from a nosocomial isolate of Staphylococcus aureus CM.S2 (IMCJ1454).
Sekiguchi J; Tharavichitkul P; Miyoshi-Akiyama T; Chupia V; Fujino T; Araake M; Irie A; Morita K; Kuratsuji T; Kirikae T
Antimicrob Agents Chemother; 2005 Sep; 49(9):3948-51. PubMed ID: 16127079
[TBL] [Abstract][Full Text] [Related]
16. Development of antibacterial compounds that constrain evolutionary pathways to resistance.
Zhang Y; Chowdhury S; Rodrigues JV; Shakhnovich E
Elife; 2021 Jul; 10():. PubMed ID: 34279221
[TBL] [Abstract][Full Text] [Related]
17. Sequence-specific 1H, 13C and 15N assignment of the TMP-resistant dihydrofolate reductase mutant DHFR(F98Y) in the ternary complex with TMP and NADPH.
Altmann S; Labhardt AM; Senn H; Wüthrich K
J Biomol NMR; 1997 Jun; 9(4):445-6. PubMed ID: 9255948
[No Abstract] [Full Text] [Related]
18. Plasmid-mediated trimethoprim-resistance in Staphylococcus aureus. Characterization of the first gram-positive plasmid dihydrofolate reductase (type S1).
Young HK; Skurray RA; Amyes SG
Biochem J; 1987 Apr; 243(1):309-12. PubMed ID: 3606580
[TBL] [Abstract][Full Text] [Related]
19. Solvent environments significantly affect the enzymatic function of Escherichia coli dihydrofolate reductase: comparison of wild-type protein and active-site mutant D27E.
Ohmae E; Miyashita Y; Tate S; Gekko K; Kitazawa S; Kitahara R; Kuwajima K
Biochim Biophys Acta; 2013 Dec; 1834(12):2782-94. PubMed ID: 24140567
[TBL] [Abstract][Full Text] [Related]
20. Cloning and characterization of dihydrofolate reductases from deep-sea bacteria.
Murakami C; Ohmae E; Tate S; Gekko K; Nakasone K; Kato C
J Biochem; 2010 Apr; 147(4):591-9. PubMed ID: 20040594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
